Literature DB >> 15763957

The differential tissue distribution of the citrus flavanone naringenin following gastric instillation.

Manal Abd El Mohsen1, Joanne Marks, Gunter Kuhnle, Catherine Rice-Evans, Kevin Moore, Glenn Gibson, Edward Debnam, S Kaila Srai.   

Abstract

Citrus flavonoids have been investigated for their biological activity, with both anti-inflammatory and -carcinogenic effects being reported. However, little information is known on the bioavailability of these compounds in vivo. The objectives of this study were to determine the tissue distribution of naringenin after gastric gavage of [3H]-naringenin to rats. Unlabelled naringenin was also used to quantify the levels of naringenin and its major metabolites in tissues and eliminated in the urine and faeces. Significant radioactivity was detected in the plasma as well as all tissues examined 2h post-gavage. After 18h, higher levels of radioactivity were retained in plasma and tissues (55% of the administered radioactivity). Investigation of the nature of metabolites, using unlabelled naringenin, revealed that the glucuronides were the major components in plasma, tissues and urine, in addition to the colonic metabolite 3-(4-hydroxyphenyl) propionic acid, detected in the urine. The aglycone was the form extensively retained in tissues after 18h post-gavage. Total identified metabolites detected after 18h in most tissues were only 1-5% of the levels detected after 2h. However, the brain, lungs and heart retained 27, 20 and 11%, respectively, relative to the total metabolites detected at 2h. While radioactive detection suggests increased levels of breakdown products of naringenin after 18 h versus 2 h, the products identified using unlabelled naringenin are not consistent with this, suggesting that a predominant proportion of the naringenin breakdown products at 18 h are retained as smaller decomposition molecules which cannot yet be identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15763957     DOI: 10.1080/10715760400017293

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  10 in total

1.  Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial.

Authors:  Candida J Rebello; Robbie A Beyl; Juan J L Lertora; Frank L Greenway; Eric Ravussin; David M Ribnicky; Alexander Poulev; Brandon J Kennedy; Hector F Castro; Shawn R Campagna; Ann A Coulter; Leanne M Redman
Journal:  Diabetes Obes Metab       Date:  2019-09-30       Impact factor: 6.577

2.  Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery.

Authors:  Minyi Guan; Xuan Zeng; Rui Shi; Yuying Zheng; Weiyang Fan; Weiwei Su
Journal:  AAPS PharmSciTech       Date:  2021-01-03       Impact factor: 3.246

Review 3.  A Review on Pharmacological and Analytical Aspects of Naringenin.

Authors:  Kanika Patel; Gireesh Kumar Singh; Dinesh Kumar Patel
Journal:  Chin J Integr Med       Date:  2014-12-10       Impact factor: 1.978

4.  Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats.

Authors:  Shiuan-Pey Lin; Yu-Chi Hou; Shang-Yuan Tsai; Meng-Ju Wang; Pei-Dawn Lee Chao
Journal:  Biomedicine (Taipei)       Date:  2014-08-13

5.  Low Molecular Weight (poly)Phenol Metabolites Across the Blood-Brain Barrier: The Underexplored Journey.

Authors:  Rafael Carecho; Diogo Carregosa; Cláudia Nunes Dos Santos
Journal:  Brain Plast       Date:  2021-02-09

6.  Naringin Supplementation during Pregnancy Induces Sex and Region-Specific Alterations in the Offspring's Brain Redox Status.

Authors:  Bernardo Gindri Dos Santos; Caroline Peres Klein; Mariana Scortegagna Crestani; Rafael Moura Maurmann; Régis Mateus Hözer; Karoline Dos Santos Rodrigues; Pauline Maciel August; Cristiane Matté
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

7.  The effect of epicatechin on oxidative stress and mitochondrial damage induced by homocycteine using isolated rat hippocampus mitochondria.

Authors:  Fatemeh Shaki; Yaghoub Shayeste; Mohammad Karami; Esmaeil Akbari; Mahdi Rezaei; Ramin Ataee
Journal:  Res Pharm Sci       Date:  2017-04

Review 8.  Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

Authors:  Erika Hernández-Aquino; Pablo Muriel
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

9.  Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery.

Authors:  Minyi Guan; Rui Shi; Yuying Zheng; Xuan Zeng; Weiyang Fan; Yonggang Wang; Weiwei Su
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

10.  Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus × aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul Brantom; Andrew Chesson; Johannes Westendorf; Paola Manini; Fabiola Pizzo; Birgit Dusemund
Journal:  EFSA J       Date:  2021-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.